Ask The Board

  1. What Are The Keys To A Good Working Relationship With A Board Of Directors? 5/1/2023

    See the answer from Joseph Ferra, CFO at Elevation Oncology.

  2. In The R&D Space, How Has The Role And Expectations Of A Quality Organization Changed Over Time? 5/1/2023

    See the answer from Jason Urban, executive director, R&D quality risk management, governance, and analytics, at Gilead Sciences.

  3. What Is The Role Of Generative AI In The Life Sciences Industry? 4/3/2023

    See the answer from John Reynders, chief data sciences officer at Neumora Therapeutics.

  4. How Will Industry Work With Congress To Make The Inflation Reduction Act (IRA) Workable? 4/3/2023

    See the answer from Paul Hastings, president and CEO of Nkarta Therapeutics and chair of the board of directors at BIO.

  5. Ongoing Economic Uncertainty And The Exit Of Generalist Investors From Biopharmaceuticals Continue To Put Pressure On Biopharma Company Leaders. What Advice Would You Offer? 3/1/2023

    See the answer from Kenneth Moch, president at Euclidean Life Science Advisors and a faculty affiliate at the Division of Medical Ethics at the NYU School of Medicine.

  6. What New Value-Based Contracting Models For Cell And Gene Therapies Will Be Needed To Promote Broad Patient Access? 3/1/2023

    See the answer from Jeffrey Berkowitz, CEO at Real Endpoints and a board member at H. Lundbeck A/S.

  7. What Tips Would You Give To An Early-Stage Biopharma CEO Preparing To Present New Clinical Data At A Medical Meeting? 2/1/2023

    See the answer from Rich Daly, president at CARsgen Therapeutics.

  8. Do You Think That Biopharmaceutical Companies Receiving An FDA Accelerated Approval Should Be Required To Enroll Patients In A Confirmatory Study Prior To Launch? 2/1/2023

    See the answer from Mary Rose Keller, VP of clinical operations at Acrivon Therapeutics.

  9. What Advice Would You Give To Small Biotechs That Have Delayed Or Canceled Plans For A Public Offering, But Still Need Funding To Advance Clinical Programs? 1/3/2023

    See the answer from Pamela Reilly Contag Ph.D., CEO and President at BioEclipse Therapeutics.

  10. What Key Characteristics Or Attributes — Beyond Functional Or Scientific Expertise — Should A CEO Look For In Considering The Addition Of A New Board Member? 1/3/2023

    See the answer from Thomas Wiggans, chairman and CEO of Pardes Biosciences.